Click to Share

Filter News
Show All Results
News By Country
News By Tag
Psychopharmacology Remove

January 2017

Public Company News

Business Press Releases

Psychopharmacology Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Mary Ann Liebert, Inc., publishers
Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of...
By Mary Ann Liebert, Inc., publishers
Two studies of the anti-depressive drug duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), compared its effectiveness and safety to either fluoxetine or placebo in children and adolescents with major depressive disorder (MDD).
By Mary Ann Liebert, Inc., publishers
Antipsychotic medications are often used for unlabeled indications, such as treatment of children and adolescents with attention-deficit hyperactivity disorder (ADHD).
By Mary Ann Liebert, Inc., publishers
The recent tragedy in Newtown, CT has renewed interest across the country in gun control measures, and it should also be a call-to-action to address gaps in mental health care, especially for children and adolescents.
By Mary Ann Liebert, Inc., publishers
urricane Sandy and the school shooting in Newtown, CT are recent examples of traumatic events that can evoke classic signs of stress reactions and the debilitating effects of posttraumatic stress disorder (PTSD) in children and teens.
By Psychopharmacology Institute
The Psychopharmacology Institute has recently published a video lecture in which Dr. Flavio Guzmán summarizes the recent literature on FDA approved antipsychotics for the management of the different phases of bipolar disorder.
By Brascoe Publishing
Johan Schioldann's latest book, History of the Introduction of Lithium into Medicine and Psychiatry, has been delayed until 2009

Page updated every 10 minutes

Like PRLog?
Click to Share